Literature DB >> 19723696

Angiotensin receptor blockers: baseline therapy in hypertension?

Franz H Messerli1, Sripal Bangalore, Frank Ruschitzka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19723696     DOI： 10.1093/eurheartj/ehp364

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  5 in total

1.  Hotline update of clinical trials and registries presented at the at the European Society of Cardiology Congress in Paris 2011.

Authors:  K Walenta; J M Sinning; C Werner; M Böhm
Journal:  Clin Res Cardiol       Date:  2011-09-30       Impact factor: 5.460

2.  Is there a link between angiotensin receptor blockers and cancer?

Authors:  Frank Enseleit; Frank Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

3.  Difficulties in achieving arterial hypertension control.

Authors:  Genel Sur; Maria Sur; Liana Kudor-Szabadi; Lucia Sur
Journal:  Maedica (Buchar)       Date:  2011-04

Review 4.  A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors.

Authors:  Helmy M Siragy
Journal:  Vasc Health Risk Manag       Date:  2011-05-19

5.  The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes.

Authors:  Raj Padwal; Mu Lin; Dean T Eurich
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-08-19       Impact factor: 3.738
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.